Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/21 17:05 | 11/19/21 | IMPL | Health | Drug | Pharmaceutical Preparations | Nelson Timothy S | WA | D | P | 108 | 10.76 | 0 | 10 | New | 10 | D | |||||||||||||||
8/19/21 17:23 | 8/18/21 | IMPL | Health | Drug | Pharmaceutical Preparations | Adams Adrian | WA | DO | CB,CEO,P | P | 280 | 13.99 | 0 | 20 | New | 20 | D | ||||||||||||||
4/29/21 21:10 | 4/27/21 | IMPL | Health | Drug | Pharmaceutical Preparations | Vivo Capital Viii, LLC | CA | T | P.d | 8,625 | 15.00 | 0 | 575 | 350 | I | ||||||||||||||||
4/29/21 20:51 | 4/27/21 | IMPL | Health | Drug | Pharmaceutical Preparations | 5Am Ventures V, L.P. | CA | T | P.d | 8,625 | 15.00 | 0 | 575 | New | 575 | I | |||||||||||||||
4/29/21 19:45 | 4/27/21 | IMPL | Health | Drug | Pharmaceutical Preparations | Norwest Venture Partners Xiv, LP | CA | T | P.d | 12,375 | 15.00 | 0 | 825 | 37 | 3,077 | D | |||||||||||||||
4/29/21 18:44 | 4/27/21 | IMPL | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 6,750 | 15.00 | 0 | 450 | 19 | 2,760 | D | |||||||||||||||
4/29/21 17:07 | 4/27/21 | IMPL | Financ | InvAdv | Investment Advice | Kkr Iris Investors LLC | NY | T | P.d | 16,500 | 15.00 | 0 | 1,100 | 41 | 3,803 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |